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This work aimed to develop and validate a simple, fast and low cost analytical method for the quantification of the bioactive 
piperine in nanoemulsions by high performance liquid chromatography with UV detection. Nanoemulsions were prepared by 
spontaneous emulsification and their physicochemical properties were evaluated. Considering the chromatographic conditions, the 
mobile phase was composed by methanol:water (70:30, v/v), Gemini® C18 column and UV detection at 343 nm. The method was 
linear in the concentration range of 5-50 μg mL-1 (r = 0.9999), specific, precise (repeatability of RSD 0.38 % and intermediate 
precision of RSD 1.11 %), accurate (101.3 %) and robust. Nanoemulsions showed nanometric droplet size, polidispersity index 
below 0.11 and negative zeta potential. The piperine content in the samples was 0.99 ± 0.01 mg mL-1. Regarding these features, 
the analytical conditions proposed in this work were adequate and effective to determine the piperine content in nanoemulsions. 
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Introduction 
 
The genus Piper belongs to the family 
Piperaceae. It has about 2000 species and it is 
found in tropical and subtropical regions. It is 
being used because of its diverse pharmacological 
properties, which includes anticancer, 
immunomodulatory, antioxidant and anti-
inflammatory properties (1). Piper nigrum L. is 
the best-known species, popularly known in Brazil 
as black pepper (2-4). Among the different types 
of peppers in the kingdom, black pepper is the 
more commercialized type being also used in 
cooking, medicinal preparations and esthetic 
products (5,6). 
The piperine (1-piperoyl-piperidine – 
Figure 1) was the first isolated amide from the P. 
nigrum species carried out by a Danish chemist, 
Hans Christian Orstedt in 1820 (2,7). Piperine is 
the main constituent alkaloid and the main 
secondary metabolite of this species. It is 
responsible for the spicy taste and it is present in 
the concentration of 50-90 g kg-1 (8). It is 
characterized by being a yellowish crystalline 
substance with a melting point between 128-130 
°C (9). Because of its insolubility in water, 
piperine acts as a weak base. In addition, it 
presents light instability being highly sensitive to 
light, which is an important characteristic (2). 
In order to circumvent the therapeutic 
substances inconvenience, several systems or 
technological products have been developed. 
Nanoemulsions are colloidal dispersions 
characterized by a system consisting of oil 
droplets stabilized by surfactants. These 
nanostructured systems have a particle diameter 
smaller than 1 μm and confer advantages, such as 
targeting the active substance at the specific site of 
action increasing the therapeutic effect and/or 
decreasing adverse effects (10-13) and promoting 
controlled release (14). Additionally, 
nanostructures can confer increased chemical 
stability to the associated active substances; for 
example, they protect them from light (15-17). 
         
 
Figure 1. Piperine chemical structure. 
 
One the most important parameters for the 
characterization of nanostructures is the content 
determination of the active substance present in 
these systems. Some methodologies by high 
performance liquid chromatography (HPLC) have 
been reported in the literature for the 
quantification of piperine. Moorthi et al. (2013) 
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(18) developed a HPLC method to quantify 
piperine and curcumine in Eudragit® E100 
nanoparticles. Another HPLC  
method was developed by De Mey et al. (2014) 
(19) to determine piperine, piperidine and N-
nitrosopiperidine in spices such as black and white 
pepper, paprika, chili pepper, allspice and nutmeg. 
Gowda et al. (2014) (20) validated a high-
performance liquid chromatography-electron 
spray ionization mass spectrometry method to 
quantify guggulsterones, piperine and gallic acid 
in commercial samples of Triphala guggulu. 
However, no HPLC methods are reported to 
quantify this isolated bioactive compound in the 
nanostructures present in this work.  
Considering this, this work aimed to 
develop and validate an analytical method by 
HPLC to quantify the piperine in nanoemulsions. 
The analytical conditions proposed in this work in 
terms of sample preparation and mobile phase 
were selected in order to obtain a simple and 
robust method with low cost. Moreover, the 
developed nanoemulsions represent an important 
nanocarrier system to promote greater bioactive 
stability and constitute a novel medicine or 
cosmetic, mainly because of the antioxidant 
(21,22) and antitumor (23) piperine properties. 
 
Experimental 
 
Material 
 
Piperine (95.98 %, w/w) was obtained 
from GAMA (São Paulo, Brazil); 
Chromatographic grade methanol was purchased 
from Tedia (São Paulo, Brazil); Ultrapure water 
was purified by the MegaPurity Mega RO 
apparatus (Rio de Janeiro, Brazil). For the 
preparation of the nanoemulsions it was used 
sorbitan monooleate (Span® 80) obtained from 
Sigma-Aldrich (Sao Paulo, Brazil); Medium chain 
triglycerides (MCT) purchased from Delaware 
(Porto Alegre, Brazil); polysorbate 80 (Tween® 
80) from Vetec (Rio de Janeiro, Brazil) and 
acetone from Química Moderna (São Paulo, 
Brazil). 
 
Nanoemulsions preparation  
 
Nanoemulsions containing piperine (P-NE) 
were prepared by the spontaneous emulsification 
method (24). The constituents of the organic phase 
were: the oil (MCT - 0.4 g), the low HLB 
surfactant (Span® 80 - 0.1925 g), the bioactive 
(0.026 g) and the solvent miscible in water 
(acetone - 67 mL). The phase was stirred for the 
components dissolution for 30 minutes. This 
phase was then injected into an aqueous phase, 
consisting of a high HLB surfactant (Tween® 80 - 
0.1925 g) and ultrapure water (134 mL) under 
constant magnetic stirring maintained for 10 
minutes after the addition of the phases. After, the 
formulation was taken to the rotary evaporator at 
40 °C to remove the organic solvent and adjust the 
final volume (25 mL) and the piperine 
concentration (1.0 mg mL-1). For comparison 
purposes, blank nanoemulsions (without piperine) 
were also prepared (NE). All formulations were 
prepared in triplicate and stored in amber glass 
vials, kept under light and environment protection. 
 
Analytical method validation 
 
For the analysis, an Agilent liquid 
chromatograph 1260 Infinity (California, USA), 
consisting of a 1260 quart pump VL, detector 
1260 VWD VL, control center and ALS automatic 
injector was used. Data were analyzed with the 
OpenLab program, version A.01.05. For the 
stationary phase, a Gemini® Phenomenex C-18 
column (150 x 4.6 mm, 5 μm along with a pre-
column Phenomenex® C-18 (4.0 x 3.0 mm, 5 μm) 
was employed. The mobile phase was composed 
of methanol:water (70:30, v/v). The equipment 
was operated at environment temperature using an 
isocratic flow of 1.0 mL min-1 and UV detection at 
343 nm. 
 
Sample preparation 
 
A 400 μL aliquot of the P-NE was diluted 
in a 20 mL volumetric flask with methanol and 
shaken at 1,100 rpm for 30 minutes. In sequence, 
the flask was calibrated to obtain a piperine 
concentration of 20 μg mL-1. For analysis in the 
chromatograph, the samples were previously 
filtered on regenerated cellulose membrane (0.45 
μm, Sartorius Stedim Biotech, Goettingen, 
Germany) and performed in triplicate. 
 
Reference solution preparation 
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The stock solution was prepared weighing 
exactly 26 mg of piperine, transferred to a 25 mL 
volumetric flask, diluted in methanol to obtain a 
concentration of 1.0 mg mL-1. After, a 400 μL 
aliquot was diluted in methanol (20 mL) in order 
to obtain the standard solution of 20 μg mL-1.  
The analyzed parameters in the validation 
of analytical method were: specificity, linearity, 
precision (repeatability and intermediate 
precision), accuracy and robustness (25, 26). 
 
Specificity 
 
To evaluate the method specificity, 
nanoemulsions were used without the presence of 
the bioactive; however, they contained other 
excipients. For this, the samples were submitted to 
the same process of the samples containing the 
bioactive, injected into the chromatograph and 
analyzed for possible interference of the 
formulation constituents. In addition, to determine 
the piperine chromatographic peak purity, another 
chromatograph was used (Shimadzu LC-20A, 
Kyoto, Japan) equipped with LC-20AT pump, 
SPD-M20A PDA detector and CBM-20A 
controller system. The same analytical conditions 
previously described were used. 
 
Linearity and detection and quantification 
coefficients 
 
Analytical curves were prepared from the 
piperine stock solution. Aliquots of this solution 
were diluted in methanol, in order to obtain 5, 10, 
20, 30, 40 and 50 μg mL-1 piperine solutions. 
Three independent analytical curves were 
constructed and the linearity was obtained by 
linear regression using the least squares method 
and analyzed by analysis of variance (ANOVA). 
From the analytical curve, the limits of 
detection and quantification were calculated 
following equations 1 and 2: 
 
LD = 3.3 x SD/S (1) 
LQ = 10 x SD/S (2) 
 
Where SD = standard deviation of the intercept 
and S = slope of the analytical curve 
 
Precision 
 
Precision was obtained from the analysis 
of repeatability and intermediate precision. The 
repeatability was evaluated by analyzing six 
distinct samples of 20 μg mL-1 performed on the 
same day and under the same experimental 
conditions. For the intermediate precision, three 
samples of the same concentration (20 μg mL-1) 
were analyzed on three different days. The results 
were evaluated and expressed in relation to the 
relative standard deviation (RSD). 
 
Accuracy 
 
Accuracy was assessed by the recovery 
test, expressed by the quantity of piperine 
recovered from the samples (n=3). For the test, 
three samples containing 200 μL of the 
nanoemulsions were extracted in methanol, in 
order to obtain 10 μg mL-1 of piperine solution. To 
these samples were added known concentrations 
of the stock solution to obtain concentrations of 
16, 20 and 24 μg mL-1 of bioactive, corresponding 
to 80, 100 and 120% of the usual analysis 
concentration (20 μg mL-1). 
 
Robustness 
 
The method robustness was evaluated 
using the following parameters: wavelength (341 
and 345 nm), proportion of the mobile phase 
(65:35 and 75:25, methanol:water) and exchange 
Equipment (Schimadzu LC-20A, Kyoto, Japan). 
 
Nanoemulsions physicochemical characterization 
 
After preparation, the nanoemulsions were 
evaluated in relation to their physicochemical 
properties. The analyses were made in triplicate. 
The pH determination was performed in a 
potentiometer (Seven Easy, Metler Toledo, Brazil) 
previously calibrated with buffer solutions pH 4.0 
and 7.0 directly in the samples. 
The samples were evaluated in relation to 
the granulometric profile by laser diffraction 
(Mastersizer® 3000E, Malvern Instruments). 
Analyses were performed in water (refractive 
index 1.33) and agitated at 1,750 rpm. Results 
were analyzed according to Mie Theory of light 
scattering considering the refractive index of MCT 
(1.46). 
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Mean droplet diameter and polydispersity 
index of the nanoemulsions were determined by 
correlation spectroscopy of photons (Zetasizer® 
Nanoseries, Malvern Instruments) after the 
samples dispersion in previously filtered ultra-
pure water (1:500, v/v). The zeta potential was 
evaluated by electrophoretic mobility in the same 
equipment. For the analyses, the samples were 
dispersed in 10 mM NaCl solution (1:500, v/v). 
The content of piperine in the 
nanoemulsions was determined by HPLC using 
the validated methodology. In addition, the 
encapsulation efficiency was determined by 
ultrafiltration-centrifugation technique (Amicon® 
10,000 MW, Millipore) at 2,200 xG for 30 
minutes. The non-associated piperine content with 
the nanocarrier was calculated by the difference 
between the total concentration of piperine and the 
concentration found in the ultrafiltrate. 
 
Results and discussion 
 
Analytical method validation 
 
In order to develop an analytical 
methodology for the quantification of drugs 
incorporated in nanocarriers, it is necessary to 
ensure that such methodology is able to separate 
and quantify the drug from the system to which it 
is associated. Furthermore, the excipients of the 
formulation or the possible degradation products 
should also be considered. For this, HPLC is one 
of the most studied methodologies for the analysis 
of nanostructured drugs (27,28) with excellent 
sensitivity and reproducibility. 
Initially, for the selection of the ideal 
mobile phase, some tests were performed aiming 
to find a simple and low cost eluent system. There 
are some reports in the literature, but none 
exclusively about piperine (18-20). The choice for 
methanol is due to the low cost in comparison 
with other solvents, thus 100% methanol and 
methanol:water in different proportions (95:5, 
80:20 and 70:30, v/v) were tested. The use of 
100% methanol and 0.5 mL.min-1 flow rate 
resulted in a low retention time, very close to the 
dead volume (3.92 min). Similar result was found 
for the 95:5 ratio. The proportions of 80:20 and 
70:30 provided similar results, with a retention 
time of 6.29 and 6.27 min, respectively. Besides, 
theoretical plates with suitable values (4,016 and 
3,303) were found as well. However, the 
resolution and asymmetry were better for the 
70:30 ratio (4.15 and 0.81, respectively). 
The chosen mobile phase was composed of 
methanol:water (70:30, v/v), which presented to 
be a simple eluent system, in addition to providing 
a lower amount of organic solvent. This mobile 
phase is more economical than the used by De 
Mey et al. (2014) (19), which employed 100% 
methanol as the mobile phase. In another HPLC 
method (Moorthi et al. 2013) (18), the mobile 
phase was composed of an ortho phosphoric acid 
aqueous solution and acetonitrile, with a higher 
flow rate (1.2 mL min-1), which implies a more 
elaborate mobile phase and a higher associated 
cost. Therefore, the chosen mobile phase showed 
to be suitable for the analysis presenting a 
retention time around 6.3 minutes, satisfactory 
asymmetry and theoretical plates. Moreover, the 
UV scanning of piperine (Figure 2) was 
performed and the spectra shows 343 nm to be the 
wavelength of maximum absorbance of the 
bioactive. 
 
Figure 2. UV scanning of piperine (methanolic solution at 10.0 μg 
mL-1 – Shimadzu Corporation UV1800 Spectrophotometer). 
 
Regarding specificity, the method proved 
to be specific for piperine analysis, showing that 
none of the formulation excipients were eluted in 
the same retention time as the piperine peak. In 
Figure 3, the overlapping of piperine solution (P-
S) and the formulation with and without piperine 
(P-NE and NE) ratifies the absence of other peaks 
at the same retention time as the bioactive.  
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Figure 3. Chromatograms obtained by HPLC: a) nanoemulsion 
without bioactive (NE); b) methanolic solution of piperine at 20.0 
μg mL-1, and c) piperine-loaded nanoemulsion (P-NE – 20.0 μg 
mL-1). 
 
In relation to linearity, the curves were 
submitted to analysis of variance (ANOVA) 
having 
 an adequate correlation coefficient (r = 0.9999; y 
= 258166x − 103392), significant linear regression 
(Fcalculated = 29462.98 > Ftabulated = 4.75) and 
presented no linearity deviation (Fcalculated = 
2.66 < Ftabulated = 3.26), demonstrating that the 
method is linear in the concentration range of 5 to 
50 μg mL-1. The values of LQ and LD were also 
calculated and corresponded to 1.26 μg mL-1 and 
0.41 μg mL-1, respectively. 
The results of the precision (repeatability 
and intermediate precision) are described in Table 
1. The relative standard deviation (RSD) values 
found were 0.38 % and 1.11 % for repeatability 
and intermediate precision, respectively, 
demonstrating that the method is precise within 
the analyzed concentration range. The accuracy 
was evaluated by the recovery test and, the 
average percentage found was 101.35 ± 0.80 %, 
evidencing that the method is accurate (Table 2).  
 
Table 1. Results found in the precision parameter of the analytical 
method by HPLC (repeatability and intermediate precision) for the 
analysis of piperine in nanoemulsions. 
 Theoretical 
concentration     
(µg mL-1) 
Experimental 
concentration         
(µg mL-1) 
Content 
(%) 
RSD 
(%) 
Intra-day 
(n=6) 
20.0 19.99 ± 0.08 99.99 ± 
0.38 
0.38 
Inter-day      
Day 1 
(n=3) 
20.0 19.99 ± 0.05 99.96 ± 
0.25 
0.25 
Day 2 
(n=3) 
20.0 19.68 ± 0.17 98.42 ± 
0.83 
0.85 
Day 3 20.0 19.98 ± 0.27 99.92 ± 1.36 
(n=3) 1.36 
Average 
(n=9) 
20.0 19.89 ± 0.22 99.43 ±  
1.11 
1.11 
 
Table 2. Results found in the accuracy of the analytical method for 
the analysis of piperine in nanoemulsions by HPLC (n=3). 
Sampl
e 
10 μg 
mL-1 
Concentration (µg 
mL-1) 
Recover
y 
(%) 
RS
D 
(%) 
Mean 
recovery 
(%) Added Recove
red 
 6.00 6.03 ± 
0.10 
100.59 
± 1.68 
  
 10.00 10.22 ± 
0.14 
102.19 
± 1.39 
0.7
9 
101.35 ± 
0.80 
 14.00 14.18 ± 
0.06 
101.27 
± 0.40 
  
The results obtained for the analytical 
method robustness are showed in Table 3. The 
small variations in the wavelength, proportion of 
the mobile phase and equipment change did not 
affect the chromatographic method developed, 
indicating the robustness of the same. 
 
Table 3. Analysis of the analytical method robustness by HPLC for 
the quantification of piperine in nanoemulsions. 
Conditions Theoretical 
plates 
Tail 
factor 
Retention 
time 
Piperine 
content 
(%) 
RSD 
(%) 
Recommended 
conditions 
3373.7 0.33 6.01 100.01 
± 0.71 
0.71 
Mobile phase 
(v/v) 
     
65:35 3824 0.82 10.02 99.81 ± 
0.28 
0.28 
75:25 3425 0.02 4.40 100.02 
± 0.98 
0.98 
λ (nm)      
341 3390.3 0.33 6.00 99.57 ± 
0.64 
0.65 
345 3394.3 0.33 5.99 99.46 ± 
0.33 
0.34 
Equipment      
Shimadzu 
HPLC 
4978.9 1.17 5.80 99.41 ± 
1.08 
1.08 
 
Nanoemulsions physicochemical characterization 
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After preparation, the formulations were 
macroscopically evaluated, presenting a milky and 
opalescent aspect, bluish-like appearance (Tyndall 
effect), known as the Brownian motion of 
colloidal systems. 
Piperine-loaded nanoemulsions (P-NE) 
and blank formulations (NE) presented, 
respectively, nanometric droplet size (182 ± 2 and 
176 ± 2 nm) and polydispersity index below 0.15 
(0.09 ± 0.04 and 0.10 ± 0.04) showing the 
adequate systemic homogeneity. The results of the 
droplet size by laser diffraction added to the 
previous one demonstrated a nanometric 
distribution, with a unimodal peak, without the 
presence of micrometric particles. The 
nanoemulsions presented Span values close to 
unity (0.628) and D [4,3] of 0.471 μm, confirming 
the homogeneity of the system, without the 
presence of microparticles (Figure 4). It can also 
be observed that the addition of the bioactive in 
the formulations did not influence the size 
(p>0.05). Savian et al. (2015) (17) found similar 
results using the same preparation method to 
prepare dithranol-loaded nanoemulsions. 
 
Figure 4. Droplet size distribution of P-NE (1.0 mg mL-1) analyzed 
by laser diffraction. 
 
Regarding the pH, the formulations 
presented acidic values (6.38 ± 0.09 and 6.27 ± 
0.07 for P-NE and NE, respectively). Slightly 
higher pH values were found when the bioactive 
was added to the formulations, probably because 
of the piperine physicochemical properties. 
In relation to zeta potential, the samples 
presented negative values (-6.3 ± 0.4 and -8.5 ± 
0.4 mV for P-NE and NE, respectively), which 
was caused by the adsorption of polyssorbate 80 
molecules to the oil-water interface. The low zeta 
potential values, in modulus, are typical for 
polyssorbate 80, a nonionic surfactant, and the 
presence of impurities, such as fatty acids, 
produces negative charge oil droplets (29, 30). 
 Regarding the bioactive content, the 
nanocarriers presented values close to the 
theoretical value (0.99 ± 0.01 mg mL-1) and 
encapsulation efficiency of 98.5 ± 0.1 %. It is 
important to mention that our results are 
satisfactory and showed the high piperine capacity 
of being associated with the nanoemulsions 
proposed in this work, in comparison to other 
works reported in the literature. Pachauri et al. 
(2015) (31) developed PEG-PLGA nanoparticles 
containing piperine, which presented 
encapsulation efficiency around 38 %; and in 
other two studies, values of 78 % and 94 % were 
obtained by Boddupalli et al. (2013) (32) and 
Moorthi (2013) (18), respectively. 
 
Conclusions 
 
A fast, simple and efficient method by 
HPLC with UV detection was developed for the 
quantification of piperine in nanoemulsions. The 
proposed method proved to be specific, linear, 
precise, accurate and robust. The results 
demonstrated that the method can be a suitable 
technique to quantify piperine in nanoemulsion 
formulations and can be used in bulk form, 
encouraging its application for quality control. In 
addition, this work showed the possibility of the 
association of piperine with nanoemulsions 
presenting nanometric droplet size and efficiency 
association of about 98 %, which are considered 
satisfactory characteristics for this type of 
nanocarrier. 
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